[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy]

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Abstract Text:

M ,E Cervera,

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Publishing Authors By Initials

M ,E Cervera,

For similar eye diseases: vitreous detachment research abstracts see: eye diseases: vitreous detachment research

PUBMED ID PMID:

MEDLINE DATE:

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Journal Published:

PUBLICATION TYPE: Editorial

Journal: Archivos de la Sociedad Española de Oftalmología

VOLUME: 82

Page Numbers: 465-6

Journal Abbreviation:

ISSN: 0365-6691

DAY: 26

MONTH: Aug

YEAR: 2007

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Information

Number of References:

LANGUAGE: spa

NlmUniqueID: 1304603

[Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Keywords Mesh Terms:

KEYWORDS: Vitreous Detachment

MESH TERMS: etiology

Chemical & Substance for Abstract: [Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy] Information

Substance Name: Plasmin

Registry Number: EC 3.4.21.7

Grant and Affiliation Information for [Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy]

AFFILIATION:

Country: Spain

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Soc Esp Oftalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy Related Publications

• Anti-chromatin (anti-nucleosome) antibodies: Diagnostic and clinical value.
• Antiphospholipid syndrome dilemmas still to be solved: 2008 status.
• Asherson's Syndrome of the Catastrophic Antiphospholipid Antibodies.
• CF2 activity and enhancer integration are required for proper muscle gene expression in Drosophila.
• Clinical and neuroendocrine features of endogenous unipolar and bipolar depression.
• Cross-amplification and sequence variation of microsatellite loci in Eurasian hard pines.
• Development and validation of an instrument to predict probability of home discharge from a geriatric convalescence unit in Spain.
• Lessons from the "Euro-Phospholipid" project.
• Measurement of creatinine in whole blood samples supplemented to achieve increased creatinine concentrations.
• Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.
• Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS") Semantic or antisemantic?
• Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
• Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients.
• Relapsing catastrophic antiphospholipid syndrome: report of three cases.
• Ron asherson.
• The PUA domain - a structural and functional overview.
• Treatment of gangrenous pulps.
• [Brilliant blue G-assisted capsulorhexis: a good help for phacoemulsification surgeons in training]
• [Early diagnosis of systemic lupus erythematosus. A challenge for clinicians of different specialties]
• [Not Available.]
• [Posterior vitreous detachment and pharmacologic vitreolysis: the new age of enzymatic vitrectomy]
• [The aborigene of the Chaco]